UMass Chan Scientists Develop mRNA Immunotherapy Effective Against Pancreatic Tumors in Mice

Scientists at UMass Chan Medical School developed an mRNA immunotherapy that eliminated pancreatic tumors in about 50% of treated mice. These mice remained disease-free for a year post-treatment, with findings published in Nature Communications. This approach, combining immune cytokine and tumor-associated antigen mRNAs, offers a potentially transformative strategy for pancreatic ductal adenocarcinoma and other immune-resistant cancers, showing promise for future human therapies.